MWR
CELG

McAdams Wright Ragen’s Celgene Corp CELG Stock Holding History

McAdams Wright Ragen’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$731K Sell
7,714
-1,718
-18% -$155K 0.04% 223
2014
Q2 		$810K Sell
9,432
-412
-4% -$31.3K 0.05% 212
2014
Q1 		$687K Sell
9,844
-7,900
-45% -$626K 0.04% 211
2013
Q4 		$1.5M Buy
17,744
+3,390
+24% +$268K 0.1% 155
2013
Q3 		$1.11M Buy
14,354
+9,182
+178% +$643K 0.09% 153
2013
Q2 		$303K Buy
+5,172
New +$311K 0.02% 271

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

McAdams Wright Ragen's CELG Position: Q3 2014 in Review

McAdams Wright Ragen reduced its Celgene Corp (CELG) stake by 18% in Q3 2014, selling an estimated $155K and leaving 7,714 shares worth $731K. The position accounts for 0.04% of the portfolio, ranked #223.

McAdams Wright Ragen first reported a position in CELG in Q2 2013 and has held it in 6 quarters since. The position peaked at $1.5M in Q4 2013. 1,031 funds tracked by Wall St. Rank hold CELG as of Q3 2014.

  • McAdams Wright Ragen held 7,714 shares of Celgene Corp worth $731K as of Q3 2014.
  • McAdams Wright Ragen sold 1,718 Celgene Corp shares in Q3 2014, an estimated $155K.
  • Celgene Corp made up 0.04% of McAdams Wright Ragen's portfolio in Q3 2014, its #223 holding.
  • McAdams Wright Ragen first reported a position in Celgene Corp in Q2 2013 and has held it in 6 quarters since.
  • McAdams Wright Ragen's Celgene Corp position peaked at $1.5M in Q4 2013.
  • 1,031 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2014.

Based on McAdams Wright Ragen's 13F filing for Q3 2014, filed 14 Nov 2014.